Emergency Medicine
Study shows cardiac troponin concentrations at presentation are insufficient to distinguish type 1 myocardial infarction from other causes of myocardial injury.
6 Sep, 2021 | 10:42h | UTC
Commentary on Twitter
Cardiac troponin release kinetics: levels at presentation cannot distinguish type 1 MI from other causes of injury or infarction. Results now online @CircAHA https://t.co/8cjyl6SGai@HighSTEACS @chapdoc1 @djlmed @DorienKimenai @EdinUniCVS pic.twitter.com/v0RoD532Jx
— Ryan Wereski (@RyanWereski) June 25, 2021
Differentiating central from peripheral causes of acute vertigo in an emergency setting with the HINTS, STANDING, and ABCD2 tests: A diagnostic cohort study.
6 Sep, 2021 | 10:36h | UTCDifferentiating central from peripheral causes of acute vertigo in an emergency setting with the HINTS, STANDING, and ABCD2 tests: A diagnostic cohort study – Academic Emergency Medicine (link to abstract – $ for full-text)
Commentary: Can We Detect Central Vertigo on Exam? – Journal Feed
RCT: Baricitinib reduced mortality in hospitalized adults with COVID-19.
2 Sep, 2021 | 10:17h | UTCCommentaries:
Commentaries on Twitter
NEW—Baricitinib did not improve the composite primary endpoint of progression to NIV,
high-flow O2, IMV, or death; however, it did reduce 28-day all-cause mortality by 38·2% vs placebo (HR 0·57 [95% CI 0·41–0·78])Read the COV-BARRIER study: https://t.co/QrU6GW0XcQ#ISICEM2021
— The Lancet Respiratory Medicine (@LancetRespirMed) September 1, 2021
(thread – click for more)
1/🧵💥 NEW COVID THERAPY SAVES LIVES
Adding baricitinib to steroids will save 1,000s of hospitalized #COVID pts. Our @LancetRespirMed COV-Barrier study is FREE.
I explain👇why it’s such a great #Pandemic discovery story: a new way to ⬇️ COVID19 deaths.https://t.co/8I5BlwyT2R pic.twitter.com/6KcfQrljqC
— WesElyMD (@WesElyMD) September 1, 2021
Scientific Statement: Coronavirus Disease-2019 and Heart Failure.
2 Sep, 2021 | 10:08h | UTC
Commentary on Twitter
Released today: Coronavirus Disease-2019 and Heart Failure: A Scientific Statement from @HFSA, published in @JCardFail. @dranulala @ankeetbhatt @EricAdler17 @BhadeliaMD @AshishCorrea @ersied727 @heartofthemater @AndrewJSauer @NMHheartdoc @scottdsolomon https://t.co/fyWab32ruU pic.twitter.com/8pNY60I6gD
— HFSA (@HFSA) September 1, 2021
RCT: Among critically ill patients, targeting oxygenation to a low-normal range vs. high-normal range did not result in a reduction in organ dysfunction.
2 Sep, 2021 | 08:23h | UTCEffect of Low-Normal vs High-Normal Oxygenation Targets on Organ Dysfunction in Critically Ill Patients: A Randomized Clinical Trial – JAMA (free for a limited period)
Related:
M-A of randomized trials: Conservative oxygen therapy for critically ill patients.
Oxygen administration for patients with ARDS – Journal of Intensive Care
Commentary on Twitter
Multicenter RCT found, among critically ill patients, targeting oxygenation to a low-normal range compared with a high-normal range did not result in a statistically significant reduction in organ dysfunction https://t.co/lEq28bqmM4 #ISICEM21
— JAMA (@JAMA_current) August 31, 2021
RCT: In patients with acute hypoxemic respiratory failure, a strategy of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal was not associated with improved outcomes.
2 Sep, 2021 | 08:21h | UTCEffect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial – JAMA (free for a limited period)
Related: Randomized Trial: Low vs Intermediate Tidal Volume Strategy in ICU Patients Without ARDS
Commentary on Twitter
In this randomized clinical trial that included 412 adults, 90-day mortality was 41.5% in the extracorporeal carbon dioxide removal group and 39.5% in the standard care group, a difference that was not statistically significant https://t.co/jhCY2r4qjX #ISICEM21
— JAMA (@JAMA_current) August 31, 2021
RCT: Ketamine administration in patients with acute painful sickle cell crisis was effective for pain control and reduced the cumulative morphine dose in the emergency department.
2 Sep, 2021 | 08:11h | UTCKetamine Administration for Acute Painful Sickle Cell Crisis: A Randomized Controlled Trial – Academic Emergency Medicine (link to abstract – $ for full-text)
Review: Initial antimicrobial management of sepsis – immediate, empiric, broad-spectrum therapy is key, but it must be accompanied by a commitment to de-escalation and antimicrobial stewardship.
1 Sep, 2021 | 08:59h | UTCInitial antimicrobial management of sepsis – Critical Care
Cohort study: A strategy combining a rapid antigen test and chest CT was effective in ruling out COVID-19 in the emergency department.
31 Aug, 2021 | 09:00h | UTC
Cohort study: Patients with Covid-19 infected with the Delta variant are twice as likely to need hospital admission or emergency care attendance.
29 Aug, 2021 | 19:02h | UTCCommentaries:
Covid: Delta variant patients twice as likely to need hospital care – BBC
Covid-19 hospitalization risk doubles with Delta variant, UK study suggests – CNN
Commentary on Twitter
The Delta variant is bad enough, but there has been debate as to whether it, per se, carries a higher risk of hospitalization (H) beyond its very high contagiousness. A new, rigorous study shows a doubling of the H rate https://t.co/qom8l6fw4v pic.twitter.com/CwXPOU0YWi
— Eric Topol (@EricTopol) August 27, 2021
#ESCCongress – RCT: Immediate coronary angiography after out-of-hospital cardiac arrest without ST-segment elevation did not improve outcomes compared to delayed/selective angiography.
29 Aug, 2021 | 18:12h | UTCNews release: Trial does not support early coronary angiography in cardiac arrest without ST elevation – European Society of Cardiology
Commentaries:
Commentary on Twitter
TOMAHAWK: In patients without ST elevation and OHCA, immediate coronary angiography provided no benefit over delayed. #ESCCongress https://t.co/7IKJ1y4B8v pic.twitter.com/H0cyyl18ig
— NEJM (@NEJM) August 29, 2021
#ESCCongress – Pilot study in Sweden showed drones delivered defibrillators faster than ambulances to patients with suspected cardiac arrest.
29 Aug, 2021 | 18:02h | UTCEditorial: Automated external defibrillator delivery by drones: are we ready for prime time?
News releases:
Drones delivered defibrillators to patients with suspected cardiac arrests – Karolinska Institutet
Commentary on Twitter
Just released: #drones are effective in successfully delivering #AEDs to patients with suspected out-of-hospital cardiac arrest #OHCA, with a time benefit compared to emergency medical services https://t.co/D9XOI0Pep4 #EHJ #ESCcongress #ESCYoung @ehj_ed @rladeiraslopes pic.twitter.com/oRSMdQVqAC
— European Society of Cardiology Journals (@ESC_Journals) August 27, 2021
COVID-19 associated Mucormycosis: risk factors and mechanisms of disease.
27 Aug, 2021 | 10:07h | UTCRelated: Clinical Picture: Mucormycosis after COVID-19 in a patient with diabetes. (several articles on the subject)
Commentary on Twitter
🆕💥💥Review Article #CID @IDSAInfo @jobadd
COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease #IDTwitter #medtwitter #TwitteRx https://t.co/Ob89SFNoPx pic.twitter.com/tzf7KpGVyG— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) August 22, 2021
M-A of randomized trials: Effectiveness of the modified Valsalva maneuver in adults with supraventricular – “The meta-analysis demonstrated a significantly higher success rate for reconversion to sinus rhythm when using the modified VM compared to the standard VM in patients with an SVT (odds ratio = 4.36; 95% confidence interval, 3.30–5.76; P < 0.001)”.
26 Aug, 2021 | 08:51h | UTCEffectiveness of the modified Valsalva manoeuvre in adults with supraventricular tachycardia: a systematic review and meta-analysis – European Journal of Emergency Medicine (link to abstract – $ for full-text)
Related: Randomized Trial: Standard Valsalva vs. Modified Valsalva for Cardioversion of SVT (studies and commentaries on the subject)
Video: Modified Valsalva manoeuvre for supraventricular tachycardia – The Lancet
Review: Acute and chronic hyponatremia.
25 Aug, 2021 | 08:50h | UTCAcute and Chronic Hyponatremia – Frontiers in Medicine
Related:
Podcast: Hyponatremia deconstructed
Guidelines for the Management of Exercise-Associated Hyponatremia
[Preprint] RCT: Fluvoxamine reduced the risk for ER visits and hospitalization among patients with Covid-19.
24 Aug, 2021 | 10:06h | UTCRelated:
Commentary on Twitter
@TogetherTrial Manuscript Pre-print regarding #Fluvoxamine for early #COVID19 is online athttps://t.co/teHqMlowld
demonstrating ~30% relative reduction in ER visits / hospitalizations with fluvoxamine 100mg 2x/day in a 10-site, double-blind randomized trial. #IDtwitter pic.twitter.com/727by0lqft— David Boulware, MD MPH (@boulware_dr) August 23, 2021
RCT: Awake prone positioning reduces the need for intubation in patients with COVID-19.
23 Aug, 2021 | 00:03h | UTCInvited commentary: Awake prone positioning in COVID-19: is tummy time ready for prime time?
Related:
Commentary on Twitter
Awake prone positioning of pts w/ hypoxaemic respiratory failure due to #COVID19 reduces incidence of treatment failure & need for intubation w/o any signal of harm
Meta-trial from the Awake Prone Positioning Meta-Trial Group https://t.co/GuDdjPnVps pic.twitter.com/ZS08uQN1gE
— The Lancet Respiratory Medicine (@LancetRespirMed) August 21, 2021
Study Commentaries: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial.
22 Aug, 2021 | 23:52h | UTCCommentary 1: JC: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial – St Emlyn’s
Survey: Workplace mistreatment reported frequently by emergency medicine residents.
22 Aug, 2021 | 22:18h | UTCWorkplace Mistreatment Reported Frequently by Emergency Medicine Residents – HealthDay
Original study: Prevalence of Discrimination, Abuse, and Harassment in Emergency Medicine Residency Training in the US – JAMA Network Open
Commentary on Twitter
In this study, 45.1% of emergency medicine residents reported exposure to workplace mistreatment. Interventions should be developed to ensure resident wellness and career satisfaction. @ABEMCert @EmoryMedicine @NUFeinbergMed @Rutgers_NJMS @UWMedicine https://t.co/dTrUH14NxB
— JAMA Network Open (@JAMANetworkOpen) August 20, 2021
Review: Viral respiratory pathogens and lung injury.
20 Aug, 2021 | 08:43h | UTCViral Respiratory Pathogens and Lung Injury – Clinical Microbiology Reviews
Viewpoint: Confronting the Delta variant of SARS-CoV-2.
19 Aug, 2021 | 09:03h | UTCConfronting the Delta Variant of SARS-CoV-2, Summer 2021 – JAMA
NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms.
19 Aug, 2021 | 09:06h | UTCOriginal study: Early Convalescent Plasma for High-Risk Outpatients with Covid-19 – New England Journal of Medicine
Commentary on Twitter
Convalescent plasma did not prevent disease progression in patients seen in EDs within 7 days after the onset #COVID19 symptoms. https://t.co/9gmIK3ntKH #IDTwitter pic.twitter.com/sirzn1uGL0
— NEJM (@NEJM) August 18, 2021
Hemophagocytic lymphohistiocytosis secondary to COVID-19: a case series.
19 Aug, 2021 | 08:57h | UTCHaemophagocytic lymphohistiocytosis secondary to COVID-19: a case series – The Lancet Rheumatology
Systematic review: Systemic corticosteroids for the treatment of COVID‐19.
17 Aug, 2021 | 09:11h | UTCSystemic corticosteroids for the treatment of COVID‐19 – Cochrane Library
Commentary on Twitter (thread – click for more)
JUST PUBLISHED – Systemic #corticosteroids for the treatment of #COVID19 from @CochraneHaem – https://t.co/l4V993gLzj 1/5 pic.twitter.com/Vjk4aHXKFV
— The Cochrane Library (@CochraneLibrary) August 16, 2021
Cohort study: Early invasive coronary angiography in patients with acute ischemic heart failure is linked to better outcomes.
17 Aug, 2021 | 08:44h | UTCCommentary: Early Invasive Angiography in Acute Heart Failure – American College of Cardiology
Commentary on Twitter
Our new paper published in #EHJ @escardio! In acute HF with features suggestive of underlying CAD (prior MI, ⬆️trop, or angina), coronary angiography within 2 weeks of admission was associated with ⬇️mortality, CV death, and HF readmissions and ⬆️ revascularization at 2 years. https://t.co/q2cpV3mcMs
— Leah Kosyakovsky (@leahkosyakovsky) July 31, 2021


